AUSTIN, Texas, June 30, 2021 /PRNewswire/ -- Oracle
announced today that Oracle Health Sciences' Clinical One platform
has been selected by Servier to make its vision of a
next-generation clinical trial management environment a reality. To
start and manage clinical trials is a lengthy and regulated process
that entails mountains of data to account for and share with
various stakeholders.
"We were looking for a technology platform that could enable us
to innovate, modernize, and standardize our overall approach to
clinical trials," said Patricia
Belissa-Mathiot, Head of Clinical Development and R&D
CMO at Servier Group. "Following a strict and thorough review
process, it was clear that Oracle provided a comprehensive, unified
platform with a robust data approach that could support our plan
for an integrated and digitized environment. All of our processes –
from study startup through conduct and close out – will be
integrated and streamlined on the Oracle Clinical One platform. Our
teams will now be able to follow, analyze data and draw valuable
clinical insight—in a single place—which will ultimately help
accelerate bringing our therapies to market to patients waiting in
need."
Servier is a global pharmaceutical group present in 150
countries. Its growth is based on a sustained commitment to
cardiovascular and metabolic diseases, oncology and
immuno-inflammatory, and neurodegenerative diseases. The Clinical
One platform will unify the Servier clinical environment to start
new trials in a more efficient way, make mid-study changes in
real-time, and unite everyone working on a trial – from CROs to
sponsors – in a common data environment.
"Servier has long looked to technology to stay at the forefront
of the market," said Henry McNamara,
senior vice president and general manager, Oracle Health Sciences.
"With our Clinical One platform and solutions Servier can create a
technological environment that further enables it to fuel
breakthrough, life-saving discoveries. Our unified approach to
clinical trials will set Servier apart today and in the future, as
the industry continues to transform how it conducts clinical
trials."
Servier has selected Clinical One for its shared capabilities
and common functions, to unify its clinical environment, and shave
weeks off of traditional clinical operations. Clinical One will
enable significant business efficiencies from across the study
lifecycle, including capabilities like study budgeting and
forecasting, site selection and activation, randomization and trial
supply, data collection and mHealth, and clinical and operational
data management and analysis.
Servier also chose Clinical One for its ability to address
various aspects of decentralized trials. The platform will ensure
data collection from new and multiple data sources, harmonize the
data, and eliminate reconciliation by having a single source of
truth, drawing valuable clinical insights via dashboards and
KPIs.
Servier already uses Oracle Argus to process its safety
cases, ensuring a seamless end-to-end business process.
From a technical standpoint, Clinical One will significantly
reduce costs and streamline adoption by utilizing validation
packages provided with each release. As a result, Servier will
get a unified platform that is easy to use, easy to maintain, easy
to update, and easy to upgrade.
About Oracle Health Sciences
As a leader in Life
Sciences cloud technology, Oracle Health Sciences' Clinical One and
Safety One are trusted globally by professionals in both large and
emerging companies engaged in clinical research and
pharmacovigilance. With over 20 years' experience, Oracle Health
Sciences is committed to supporting clinical development,
delivering innovation to accelerate advancements, and empowering
the Life Sciences industry to improve patient outcomes. Oracle
Health Sciences. For life.
Learn more at:
Oracle Health Sciences:
https://www.oracle.com/industries/life-sciences/
Oracle Health Sciences Clinical One:
https://www.oracle.com/industries/life-sciences/data-collection
About Oracle
Oracle offers integrated suites of
applications plus secure, autonomous infrastructure in the Oracle
Cloud. For more information about Oracle (NYSE: ORCL), please
visit us at oracle.com.
Trademarks
Oracle, Java, and MySQL are registered
trademarks of Oracle Corporation.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/servier-selects-oracle-to-unify-its-clinical-trial-operations-301322365.html
SOURCE Oracle